State Street Pays $115 Mln Penalty To Resolve Potential Criminal Claims With USAO - Quick Facts

State Street Corp. (STT) announced Friday that it has resolved, or agreed to resolve, certain outstanding claims and investigations arising from its previously disclosed determination in 2015 that it had incorrectly invoiced clients for certain expenses.

In a Form 8-K filing with the U.S. Securities and Exchange Commission, State Street revealed that it paid a $115 million penalty to settle the potential criminal claims after entering into a Deferred Prosecution Agreement with the Office of the United States Attorney for the District of Massachusetts (USAO).

In May 2021, State Street also agreed to pay $2.65 million to resolve a purported class action that had been commenced against it in March 2017 alleging that it had violated duties owed to retirement plan customers under the Employee Retirement Income Security Act.

In April 2021, State Street agreed, subject to court approval, to resolve a derivative complaint against certain of its past and present officers and directors to recover alleged losses incurred by it relating to the invoicing matter and to another previously disclosed matter and to pay a fee to plaintiff's counsel.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings.
Follow RTT